Researchers examine molecular relationships between diabetes and heart disease

February 19, 2014 by Sathya Achia Abraham
Proposed mechanisms of cardio protection by rapamycin in type 2 diabetes. Rapamycin inhibits mTOR signaling and subsequently prevents endothelial dysfunction, obesity, hyperglycemia, insulin resistance, inflammation and oxidative stresses. This eventually prevents diabetic-induced cardiac dysfunction in type 2 diabetes. Credit: Anindita Das, Ph.D./ VCU.

(Medical Xpress)—Chronic treatment with low doses of a drug used to boost organ survival in transplant patients has been found to improve metabolism and heart dysfunction in an animal model, according to a new study from Virginia Commonwealth University.

As the number of patients with type 2 diabetes reaches epidemic proportions worldwide – and is expected to double during the next 20 years – researchers are working to gain a basic understanding of the molecular relationships between diabetes and heart disease to identify new drug targets. Diabetes is associated with heart attack, and patients with elevated fasting glucose are at a three-fold increased risk of mortality following a heart attack.

In a study published Feb. 14in the Journal of Biological Chemistry, researchers report that rapamycin, an antibiotic used to boost organ survival in , may protect the heart against complications associated with type 2 diabetes in an .

Using cutting-edge physiological, molecular and proteomic approaches, the team closely examined a key signaling pathway called mammalian target of rapamycin (mTOR). It is a signaling pathway responsible for the regulation of cell growth and metabolism, and has been implicated in a number of human diseases, including diabetes.

"Rapamycin treatment improves metabolism in diabetic mice with significant reduction in body weight, heart weight, plasma glucose, insulin levels and triglyceride levels," said contributing author Rakesh C. Kukreja, Ph.D., professor of medicine, Eric Lipman Chair of Cardiology and Scientific Director at the Virginia Commonwealth University Pauley Heart Center.

"In addition, the drug prevents cardiac dysfunction in , possibly through reducing oxidative stress and altering proteins that assist in maintaining the contractility of the diabetic heart," said Anindita Das, Ph.D., assistant professor of medicine at VCU, who led the study.

In 2006, in a study published in the Journal of Molecular and Cellular Cardiology, the team reported a protective role of rapamycin against in a non-diabetic animal model.

According to Das and Kukreja, further research is needed to understand the molecular mechanisms underlying metabolic and heart function benefits of rapamycin in patients with diabetes. The team has plans for new studies in translational animal models of to show that rapamycin can minimize damage to the heart after an acute .

"These investigations may help in rapid initiation of clinical trials for safe development of this promising therapy in patients," Kukreja said.

Explore further: Study reveals how cancer drug causes diabetic-like state

Related Stories

Study reveals how cancer drug causes diabetic-like state

April 3, 2012

Scientists at Dana-Farber Cancer Institute have discovered why diabetic-like symptoms develop in some patients given rapamycin, an immune-suppressant drug that also has shown anti-cancer activity and may even slow ageing.

Sugar overload can damage heart, research shows

June 14, 2013

Too much sugar can set people down a pathway to heart failure, according to a study led by researchers at The University of Texas Health Science Center at Houston (UTHealth).

Recommended for you

An accessible approach to making a mini-brain

October 1, 2015

If you need a working miniature brain—say for drug testing, to test neural tissue transplants, or to experiment with how stem cells work—a new paper describes how to build one with what the Brown University authors say ...

Tension helps heart cells develop normally in the lab

October 1, 2015

The heart is never quite at rest, and it turns out that even in a lab heart cells need a little of that tension. Without something to pull against, heart cells grown from stem cells in a lab dish fail to develop normally.

Dormant viral genes may awaken to cause ALS

September 30, 2015

Scientists at the National Institutes of Health discovered that reactivation of ancient viral genes embedded in the human genome may cause the destruction of neurons in some forms of amyotrophic lateral sclerosis (ALS). The ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.